A popular colorimetric analysis for serum acetaminophen, based on ring-nitrationof the drug, is demonstrated to yield both "false positives" and erroneously high results for serum from uremic patients. The interference appears to be anionic at physiologicalpH, and correlates significantly with serum creatinine concentration and with the magnitude of the "anion gap." A modification of the analysis involving extraction of the acetaminophen with ether eliminates the interference. As little as 10 mg of drug per liter can be accurately measured in serum by the proposed procedure. Analytical recovery was 97 % at a concentration of 1 gIL. Coefficients of variation for the analysis at respective concentrations of 100 and 500 mg/L were: The diagnosis and treatment of acetaminophen poisoning are based largely on information concerning the concentration of the drug in serum rather than on the dose of drug ingested (1 , 3). Treatment consists of oral administration of massive doses of sulfhydryl-containing compounds (e.g., acetylcysteme)over several days, which requires hospitalization of the patient and is not without major side effects (3). Consequently, it is usually utilized only when serum acetaminophen concentrations suggest the likelihood of hepatotoxicity (i.e., when the concentration exceeds 300 mg/L at 4 h or more after ingestion, or 50 mgfL at 12 h or more after ingestion, or when the drug's biological half-life in serum exceeds 4 h) (3).
and even chronic excessive ingestion of the drug have been characterized by hepatotoxicity (including fatal hepatic necrosis) (1) (2) (3) (4) . Although less well documented, nephrotoxicity has also been associated with acetaminophen overdose (2, 5).
The diagnosis and treatment of acetaminophen poisoning are based largely on information concerning the concentration of the drug in serum rather than on the dose of drug ingested (1 , 3) . Treatment consists of oral administration of massive doses of sulfhydryl-containing compounds (e.g., acetylcysteme)over several days, which requires hospitalization of the patient and is not without major side effects (3) . Consequently, it is usually utilized only when serum acetaminophen concentrations suggest the likelihood of hepatotoxicity (i.e., when the concentration exceeds 300 mg/L at 4 h or more after ingestion, or 50 mgfL at 12 h or more after ingestion, or when the drug's biological half-life in serum exceeds 4 h) (3).
Treatment
is best initiated as quickly as possible. The implications of these factors for the clinical laboratory are obvious: a rapid, reliable method for acetaminophen analysis should be available at all times. Acetaminophen has been measured in serum by various techniques: ultraviolet (6) and visible (7-12) spectrophotometry, gas-liquid chromatography (13), and "high-pressure" liquid chromatography (14-16). Despite the advent of chromatographic assays for acetaminophen, spectrophotometric techniques have remained popular in many laboratories owing to their relative simplicity, economy, and quick turnaround time, one of the most widely used assays for acetaminophen being the colorimetric method of Chafetz et al. (7) , as modified for use in serum by Glynn and Kendal (8) and Walberg (9) . This method has been recommended by the Figure 1 ). I find this method to be generally quite suitable for use in the rapid diagnosis of acetaininophen intoxication, but I have encountered serious endogenous interferences (both "false positives" and erroneously increased acetaminophen concentrations) when the procedure is applied to the serum of uremic patients. This is of particular concern when the analysis is requested to explain the etiology of renal failure.
In the present study this interference is characterized, and a rapid, reliable modification of the procedure suitable for use in uremia is presented.
Materials and Methods

Apparatus
Absorbances were measured with a Model 25 double-beam recording ultraviolet-visible spectrophotometer (Beckman Instruments, Inc., Fullerton, CA 92634).
Reagents and Standards
All reagents were of analytical (AR) grade. the stock standard and dissolve the residue in 50 mL of water (for method 1 below) or drug-free serum (for method 2). For working standards, appropriately dilute the 1000 mgfL standard with water or drug-free serum to produce the desired concentrations (usually 20-300 mg/L). Prepare at the time of analysis.
Procedure
Method I (conventional colorimetric procedure) (7-9). Pipet 1 mL of sample (patient's serum, aqueous working standards, and a suitable commercial lyophilized control1) into 15-mL glass test tubes. Add 2 mL ofO.6 mol/L trichloroacetic acid to precipitate the proteins and mix well. Centrifuge (3000 x g, 10 mm) and carefully transfer exactly 2 mL ofeach clear, colorless supernate to a second series of test tubes. Pipet 0.5 mL of 6.0 mol/L HC1 and mix. Generate nitrous acid by adding 0.5 mL of 1.4 mol/L NaNO2, mix well, and let stand for 2 mm. Add 0.5 mL of a 1. Measure the absorbance of each sample at 430 nm, with water as the reference. Calculate the concentration of acetaminophen in the patients' sera and control by comparing their absorbances with those of the working standards.
Serum Samples from Uremic Patients
Sera having a creatinine concentration >30 mgfL and (or) urea nitrogen concentration >500 mg/L were gleaned as residual samples from 58 different patients known not to have ingested acetaminophen.
The samples were analyzed by the conventional colorimetric procedure (method 1). Additional sera from 20 of these patients were analyzed by both the conventional colorimetric procedure (method 1) and the proposed modification of the procedure (method 2).
'One such control (concentration, 20 mgfL) is supplied by Utak Laboratories, Saugus, CA 91350.
Results
The urea nitrogen concentrations in the sera of the 58 different uremic patients ranged from 80 to 1420 mg/L (, 700; SD, 260), and the creatinine concentrations from 9 to 239 mg/L (Y, 88; SD, 53). The patients with normal urea nitrogen concentrations had abnormal creatinine concentrations, and vice versa. The apparent "acetaminophen" concentrations in these sera ranged from 3 to 58 mg/L (, 28; SD, 13) when the samples were analyzed by method 1. In contrast, "background" concentrations in the sera of 10 drug-free volunteers with normal renal function ranged from 5 to 16 mg/L (, 9; SD, 4).
When additional sara from 20 ofthe 58 uremic patients were analyzed by both the conventional colorimetric procedure (method 1) and the proposed extraction procedure (method 2), significant differences were found (Table 1) . "Acetaini- with the nitration method for acetaminophen (7, 8) .
Strong acids such as salicylate and its congeners are not extracted under the conditions of the proposed assay.
After correction for aliquotting losses with the proposed method, a plot of absorbances obtained by the conventional colorimetric method (x) vs the proposed extraction method (y) was linear (r 0.9993) for seven concentrations over the 0-1000 mgfL range studied in non-uremic serum ("least- 
0.0185).
The mean apparent "acetaminophen" concentration (28 mg/L) by method 1 in the 58 uremic patients differed significantly from that in the 10 normal volunteers (9 mg/L) when Student's t-test was applied (t = 8.842, p <0.01). The "acetaminophen" concentration showed a statistically significant correlation with the serum creatinine by "least-squares" regression analysis (r 0.698, p <0.01) but no significant correlation with urea nitrogen. Of the uremic patients, 11 had normal "background" when their sera were analyzed by method 1. However, these 11 had significantly lower creatinine concentrations (, 33 mg/L; SD, 12) than the remaining 47 (7, 102 mgfL; SD, 51) (t 8.376, p <0.01). For the entire series, whenever the creatinine was >56 mgfL (as was the case for 36 sera), the "background" concentration exceeded that for normal serum by method 1.
For 49 uremic patients the "anion gap" was determinable and was estimated by the difference (Na + K) - not probable, that the interference may be due to ring nitration of the phenolic acids encountered in uremic serum. Creatinine and urea themselves are not responsible for the interference, because an aqueous creatinine standard of concentration 10 g/L and an aqueous urea standard of concentration 100 g/L failed to react when method 1 was used.
Use of the proposed extraction method decreases interferences encountered in uremia to the "background"
concentrations noted in normal sera. The anionic interferences are not recovered under the conditions of physiological pH at which the ether extraction is performed.
However, acetaminophen is almost completely recovered. Hexane is utilized to remove turbidity due to lipids that are co-extracted with acetaminophen.
The conventional colorimetric assay (7) (8) (9) should be considered unsuitable for use in uremia. In the present study, use of this assay gave "false positive" acetaminophen concentrations ranging up to 58 mg/L. Although this concentration may not appear to be extraordinarily high, it can be consistent with acetaminophen overdose if more than 12 h have elapsed since drug ingestion (3) . Furthermore, such a finding may suggest a false etiology for the patient's compromised renal status if it is not already explained. Finally, if acetaminophen is truly present in uremic serum, the use of method 1 would yield inappropriately high results, perhaps suggesting overdose in an otherwise therapeutically dosed patient.
If for no other reason, analysis for acetaminophen should be included in every routine toxicology panel because use of the "antidote" (e.g., acetylcysteine) is based upon information on the drug concentration in serum. The proposed method can be performed rapidly, easily, and economically. In addition, samples can be conveniently batched and assayed simultaneously.
The immediate
development of color in the assay permits rapid identification of "positives" before spectrophotometric quantitation.
Current chromatographic tech-
niques may not offer all of these advantages. The proposed assay can be used either as the laboratory's primary method for acetaminophen analysis or as an alternative method whenever the conventional procedure yields a "positive" result and the renal function of the patient is unknown. I consider the proposed method to be reliable, accurate, and specific, and recommend it for routine use in the clinical laboratory.
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Methods
Whole blood was obtained from eight healthy adult volumteers and from the umbilical cord of seven normal, full-term infants of appropriate weight for gestatiohal age. Without delay, 4-mL aliquots were treated with sodium heparin (5 mt. Co., Yellow Springs, OH 45387). Duplicate glucose determinations were made at 1, 2, 4, and 6 h for the NsF-treated specimens and at 2, 4, and 6 h for the clotted specimens. The serum and clot were not separated or agitated during the study. The glucose value at time 0 for the heparin-treated samples for both the infant and adult specimens was used as the reference (time-zero) glucose value for NaFtreated and clotted specimens from infants and adults. All samples were left at room temperature throughout the study (25-27 #{176}C). Results were evaluated by the Student's t-and paired t -tests.
The study was approved by the Committee of Associates on Human Investigation at the University of South Florida. Table 1 shows the glucose changes with time for each group.
Results
The higher baselineglucosevalue in infants than in adults
partly obscures the significantly more rapid changes in glucose concentrations in infants, both with increasing time and increasing hematocrits. Decreases in glucose in samples from infants were signifi-
